Lortab and Burns second degree - a phase IV clinical study of FDA data

Summary:

Burns second degree is reported as a side effect among people who take Lortab (acetaminophen; hydrocodone bitartrate), especially for people who are female, 40-49 old, also take Ambien, and have Joint pain.

The phase IV clinical study analyzes which people have Burns second degree when taking Lortab. It is created by eHealthMe based on reports of 29,547 people who have side effects when taking Lortab from the FDA, and is updated regularly.

What is Lortab?

Lortab has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 31,285 Lortab users. Check the latest studies of Lortab.

What is Burns second degree?

Burns second degree is found to be associated with 214 drugs and 350 conditions by eHealthMe. Check the latest studies of Burns second degree.

On Jul, 06, 2026

29,547 people reported to have side effects when taking Lortab.
Among them, 21 people (0.07%) have Burns second degree.

Among these 21 people:

What is the gender of people who have Burns second degree when taking Lortab? *

female: 61.9 %
male: 38.1 %

What is the age of people who have Burns second degree when taking Lortab? *

What are other drugs people take besides Lortab? *

What are other side effects people have besides Burns second degree? *

Oedema Peripheral (superficial swelling): 13 people, 61.90%
Stress And Anxiety: 11 people, 52.38%
Memory Loss: 11 people, 52.38%
Drug Dependence: 10 people, 47.62%
Drug Ineffective: 10 people, 47.62%
Nausea (feeling of having an urge to vomit): 9 people, 42.86%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 8 people, 38.10%
Hypersensitivity: 7 people, 33.33%
Joint Pain: 7 people, 33.33%
Application Site Vesicles (small bubble within a cell at application site): 7 people, 33.33%

What are the existing conditions these people have? *

Joint Pain: 7 people, 33.33%
Muscle Spasms (muscle contraction): 6 people, 28.57%
Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 1 person, 4.76%
Nausea (feeling of having an urge to vomit): 1 person, 4.76%
Ill-Defined Disorder: 1 person, 4.76%
Depression: 1 person, 4.76%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 4.76%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 4.76%
Cardiac Failure Congestive: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Lortab and have Burns second degree?

- Check whether Burns second degree is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lortab:

Lortab (31,285 reports)

Burns second degree treatments and more:

Burns second degree (2,151 reports)

How severe was Burns second degree and when was it recovered:

Burns second degree in Lortab

Expand to all the drugs that have ingredients of acetaminophen; hydrocodone bitartrate:

Burns second degree and drugs with ingredients of acetaminophen; hydrocodone bitartrate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lortab:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Burns second degree:

Burns second degree (214 drugs)

Browse all the conditions that are associated with Burns second degree:

Burns second degree (350 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; hydrocodone bitartrate (the active ingredients of Lortab) and Lortab (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.